ARCHIVES

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998

Funding Opportunity.

July 12, 2002

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013